Prostate Cancer Screening With cPSA Test Would Reduce Biopsies – Study
This article was originally published in The Gray Sheet
Executive Summary
Complexed prostate specific antigen (cPSA) test adoption would reduce the number of unnecessary biopsies, according to a study presented May 27 at the American Urological Association meeting in Orlando
You may also be interested in...
USPSTF Drops Opposition To Prostate Screening, Remains Skeptical
The U.S. Preventive Services Task Force will no longer recommend against routine prostate cancer screening, but cautions that the benefits have not been fully demonstrated
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.